Trial Profile
One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 11 Mar 2024
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary) ; Antiasthmatics; Prednisolone; Prednisolone; Prednisolone; Prednisone; Prednisone; Prednisone
- Indications Asthma
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms Liberty Asthma Excursion
- Sponsors Sanofi
- 08 Mar 2024 This trial has been completed in Italy, according to European Clinical Trials Database record.
- 24 May 2023 Results assessing the long-term safety and efficacy of dupilumab in children who completed VOYAGE presented at the 119th International Conference of the American Thoracic Society
- 27 Feb 2023 Results assessing the long term safety and clinical efficacy of dupilumab in children with Type 2 asthma, presented at the 2023 Annual Meeting of the American Academy of Allergy, Asthma and Immunology.